9CKC image
Deposition Date 2024-07-08
Release Date 2025-01-15
Last Version Date 2025-01-15
Entry Detail
PDB ID:
9CKC
Keywords:
Title:
Crystal structure of SMYD2 in complex with two PARP1 peptides
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Method Details:
Experimental Method:
Resolution:
2.10 Å
R-Value Free:
0.20
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:N-lysine methyltransferase SMYD2
Gene (Uniprot):SMYD2
Chain IDs:A, B
Chain Length:433
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Poly [ADP-ribose] polymerase 1, processed C-terminus
Gene (Uniprot):PARP1
Chain IDs:C, D, E, F
Chain Length:13
Number of Molecules:4
Biological Source:Homo sapiens
Primary Citation
Structure of the SMYD2-PARP1 Complex Reveals Both Productive and Allosteric Modes of Peptide Binding.
Biorxiv ? ? ? (2024)
PMID: 39677743 DOI: 10.1101/2024.12.03.626679

Abstact

Allosteric regulation allows proteins to dynamically respond to environmental cues by modulating activity at sites away from the catalytic center. Despite its importance, the SET-domain protein lysine methyltransferase superfamily has been understudied. Here, we present four crystal structures of SMYD2, a unique family member with a MYND domain. Our findings reveal a novel allosteric binding site with high conformational plasticity and promiscuity, capable of binding peptides, proteins, PEG, and small molecules. This site exhibits positive cooperativity with substrate binding, influencing catalytic activity. Mutations here significantly alter substrate affinity, changing the enzyme's kinetic profile. Specificity studies show interaction with PARP1 but not histones, suggesting targeted regulation. Interestingly, this site's function remains unaffected by active site changes, indicating unidirectional mechanisms. Our discovery provides novel insights into SMYD2's biochemical regulation and lays the foundation for broader research on allosteric control in lysine methyltransferases. Given SMYD2's role in various cancers, this work opens exciting avenues for designing specific allosteric inhibitors with reduced off-target effects.

Legend

Protein

Chemical

Disease

Primary Citation of related structures